Company news
Jianerkang Medical Co. Ltd. Class A (SSE:603205) news
Jianerkang Medical Co. Ltd. Class A news releases on 6ix. Latest, Sep 29, 2026: "JIANERKANG MEDICAL CO., LTD."Announcement on Convening the 2026 Semi-annual…
Press releases & updates
"JIANERKANG MEDICAL CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing
September 28, 2026
"JIANERKANG MEDICAL CO., LTD."Semi-annual Report for 2026
August 27, 2026
"JIANERKANG MEDICAL CO., LTD."Announcement on Implementation of Dividend Distribution for 2025
July 1, 2026
"Jianerkang Medical Co., Ltd."Announcement on Redemption at Maturity of Partial Idle Raised Funds Used for Cash Management
June 30, 2026
Announcement on Redemption upon Maturity of Partial Idle Raised Funds Used for Cash Management
June 26, 2026
Announcement on Resolutions of the 18th Meeting of the 2nd Board of Directors
June 11, 2026
Announcement on Resignation of the Chief Financial Officer
June 2, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 14, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 6, 2026
Notice on Convening the 2025 Annual General Meeting
April 23, 2026
Announcement on Conducting Forward Settlement and Sale of Foreign Exchange
December 29, 2025
Announcement on Redemption upon Maturity of Some Idle Raised Funds Used for Cash Management
November 12, 2025
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
November 3, 2025
Announcement on Q3 2025 Performance Briefing
October 30, 2025
Announcement on Completing Industrial and Commercial Change Registration
October 14, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
September 22, 2025
Announcement on Resolutions of the 9th Meeting of the 2nd Board of Supervisors
September 16, 2025
Announcement on Resolutions of the 14th Meeting of the 2nd Board of Directors
August 28, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 2, 2025
Announcement on Changing Sponsor Representative
June 23, 2025
Announcement on Convening the 2024 Annual Performance Briefing
May 27, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 13, 2025
Announcement on Listing and Circulation of Some Restricted Shares in Initial Public Offering
April 28, 2025
Announcement on Abnormal Fluctuations in Stock Trading
April 24, 2025
Notice on Convening the 2024 Annual General Meeting
April 22, 2025
Announcement on Opening a Special Settlement Account for Wealth Management Products
March 11, 2025
Announcement on Resolution of the 12th Meeting of the 2nd Board of Directors
December 23, 2024
Announcement on Completing Registration Change at Industrial and Commercial Administration Authorities and Obtaining Renewed Business License
December 18, 2024
Announcement on Resolution of the 3rd Extraordinary General Meeting in 2024
December 4, 2024
Announcement on the Appointment of Securities Affairs Representative
November 18, 2024